Pharmaceuticals

Premium

Healthcare

02 September, 2024

Searchlight: Hetero Health rebounds after post-COVID crash on manufacturing boost

Hetero Healthcare Ltd, which is a part of one of the major pharmaceutical groups in India Hetero group, witnessed a ......

Premium

Healthcare

13 August, 2024

Searchlight: Allchem Lifescience bets big on capacity expansion after record revenue

Active pharmaceutical ingredient (API) and pharma intermediates maker Allchem Lifescience recorded a rise in its topline and profitability for the ......

Premium

Healthcare

07 August, 2024

True North-backed Integrace set to add new names on cap table

Mumbai-based pharmaceutical player Integrace Pvt. Ltd, backed by Singapore’s Temasek and homegrown private equity firm True North, is in discussions to ......

Premium

Healthcare

25 July, 2024

Piramal-Bain's India Resurgence Fund in talks for stake in pharma player

India Resurgence Fund (IndiaRF), a stressed assets investment platform co-floated by Piramal Group and Bain Capital, is negotiating to pick ......

Premium

Healthcare

22 July, 2024

Searchlight: Pulse Pharma's revenue is slowing again. Can it pick up pace?

Hyderabad-based therapeutic medicines manufacturer, Pulse Pharmaceuticals Pvt. Ltd is estimated to clock a lean revenue growth for the financial year ......

Premium

Healthcare

18 July, 2024

Quadria Capital mulls another exit from India portfolio

Healthcare-focused private equity firm Quadria Capital is planning to offload its stake in an India portfolio company that it backed ......

Pro

Healthcare

17 July, 2024

Can TPG beat exit benchmark as IPO-bound portfolio firm targets rich valuation?

Private equity firm TPG has set the ball rolling to monetize its investment in another Indian company, as it extends ......

Premium

Healthcare

11 July, 2024

Suven Pharma mulls inorganic push for its core business

Private equity giant Advent International-owned Suven Pharmaceuticals Ltd is scouting for acquisitions in the technology space to bolster its contract ......

Premium

Healthcare

10 July, 2024

Iron Pillar, Kalaari & Navam-backed Vyome set for NASDAQ debut with reverse merger

Vyome Therapeutics Inc, a clinical-stage healthcare company targeting immunoinflammatory and rare diseases in the US and other global markets, has ......

Healthcare

08 July, 2024

Quadria, PremjiInvest-backed firms move a step closer to public float

Quadria-backed drugmaker Akums Drugs & Pharmaceuticals Ltd and PremjiInvest-backed float glass maker Gold Plus have received markets regulator SEBI’s nod ......